[1] Weissleder R. Molecular imaging: exploring the next frontier[J]. Radiology, 1999, 212(3): 609-614.  doi: 10.1148/radiology.212.3.r99se18609
[2] 王江涛, 韩萍.医学图像融合的临床应用与新进展[J].医学影像学杂志, 2009, 19(4): 476-478.
[3] 赵倩, 李娟, 王荣福. PET/MRI现象技术与其他分子影像技术的比较[J].中国医学装备, 2013, 10(1): 4-7.
[4] Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies[J]. Clin Radiol, 2010, 65(7): 500-516.  doi: 10.1016/j.crad.2010.03.011
[5] Lee S, Chen X. Dual-modality probes for in vivo molecular imaging[J]. Mol Imaging, 2009, 8(2): 87-100.
[6] 黄佳国, 曾文彬, 周明, 等.双模态分子影像探针研究进展[J].生物物理学报, 2011, 27(4): 301-311.
[7] Ma N, Ma C, Deng Y, et al. Advances in applications of dendritic compounds[J]. J Nanosci Nanotechnol, 2013, 13(1): 33-39.  doi: 10.1166/jnn.2013.6697
[8] Koga T, Iimura M, Higashi N. Novel peptide-shelled dendrimer with dramatically changeable thermo-responsive character[J]. Macromol Biosci, 2012, 12(8): 1043-1047.  doi: 10.1002/mabi.201100509
[9] Lo ST, Kumar A, Hsieh JT, et al. Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry[J]. Mol Pharm, 2013, 10(3): 793-812.  doi: 10.1021/mp3005325
[10] Caminade AM, Laurent R, Zablocka M, et al. Organophosphorus chemistry for the synthesis of dendrimers[J]. Molecules, 2012, 17(11): 13605-13621.  doi: 10.3390/molecules171113605
[11] Yamamoto A. Improvement of intestinal absorption of poorly absorbable drugs by polyamidoamine(PAMAM)dendrimers as novel absorption enhancers[J]. Yakugaku Zasshi, 2010, 130(9): 1123-1127.  doi: 10.1248/yakushi.130.1123
[12] Jiang YY, Tang GT, Zhang LH, et al. PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex[J]. J Drug Target, 2010, 18(5): 389-403.  doi: 10.3109/10611860903494203
[13] Tomalia DA, Reyna LA, Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging[J]. Biochem Soc Trans, 2007, 35(Pt 1): 61-67.
[14] 陈铨, 张永学.分子成像技术的研究进展[J].国际放射医学核医学杂志, 2011, 35(5): 290-295.
[15] Boswell CA, Eck PK, Regino CA, et al. Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers[J]. Mol Pharm, 2008, 5(4): 527-539.  doi: 10.1021/mp800022a
[16] Chen WT, Thirumalai D, Shih TT, et al. Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a Gd-loaded PEG-dendrimer-folate conjugate in a mouse xenograft tumor model[J]. Mol Imaging Biol, 2010, 12(2): 145-154.
[17] Ali MM, Bhuiyan MP, Janic B, et al. A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma[J]. Nanomedicine(Lond), 2012, 7(12): 1827-1837.
[18] Kosaka N, Bernardo M, Mitsunaga M, et al. MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals[J]. Contrast Media Mol Imaging, 2012, 7(2): 247-253.  doi: 10.1002/cmmi.489
[19] Franc BL, Acton PD, Mari C, et al. Small-animal SPECT and SPECT/CT: important tools for preclinical investigation[J]. J Nucl Med, 2008, 49(10): 1651-1663.  doi: 10.2967/jnumed.108.055442
[20] Criscione JM, Dobrucki LW, Zhuang ZW, et al. Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging[J]. Bioconjug Chem, 2011, 22(9): 1784-1792.  doi: 10.1021/bc200162r
[21] Parrott MC, Benhabbour SR, Saab C, et al. Synthesis, radiolabeling, and bio-imaging of high-generation polyester dendrimers[J]. J Am Chem Soc, 2009, 131(8): 2906-2916.  doi: 10.1021/ja8078175
[22] Regino CA, Walbridge S, Bernardo M, et al. A dual CT-MR dendrimer contrast agent as a surrogate marker for convection-enhanced delivery of intracerebral macromolecular therapeutic agents[J]. Contrast Media Mol Imaging, 2008, 3(1): 2-8.
[23] Wen S, Li K, Cai H, et al. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications[J]. Biomaterials, 2013, 34(5): 1570-1580.  doi: 10.1016/j.biomaterials.2012.11.010
[24] Li K, Wen S, Larson AC, et al. Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer[J]. Int J Nanomedicine, 2013, 8: 2589-2600.
[25] Chen Q, Li K, Wen S, et al. Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles[J]. Biomaterials, 2013, 34(21): 5200-5209.  doi: 10.1016/j.biomaterials.2013.03.009
[26] Akhter S, Ahmad I, Ahmad MZ, et al. Nanomedicines as cancer therapeutics: current status[J]. Curr Cancer Drug Targets, 2013, 13(4): 362-378.  doi: 10.2174/1568009611313040002
[27] Alavidjeh MS, Haririan I, Khorramizadeh MR, et al. Anionic linear-globular dendrimers: biocompatible hybrid materials with potential uses in nanomedicine[J]. J Mater Sci Mater Med, 2010, 21(4): 1121-1133.  doi: 10.1007/s10856-009-3978-8